Skip to main content
. 2004 Jun;48(6):2025–2036. doi: 10.1128/AAC.48.6.2025-2036.2004

FIG. 1.

FIG. 1.

Viral titers in the presence of candidate SPs. End1E6/E7 cells were pretreated with the indicated dose of compound for 1 h and were then challenged with serial 10-fold dilutions of HSV-2(G) (MOI, 0.01 to 1,000 PFU/cell). Plaques were counted 48 h postinfection. The results are the means ± standard deviations of two independent experiments conducted in duplicate.